insitro
Focus: insitro is a machine learning-driven drug discovery platform company based in South San Francisco, focused on applying AI to accelerate early-stage drug development across neurology, ophthalmology, metabolic diseases, and cell therapy.
Profile data last refreshed 6h ago · AI intelligence enriched 1w ago
Open Jobs
15+1 this month
Stable — net +1 jobs in 30d
5 added, 4 removed. Backfill posture.
Should You Work at insitro?
AI assessmentBest suited for ML engineers, computational biologists, and early-stage platform builders willing to bet on AI-first drug discovery rather than established development velocity.
Why Work Here
- Opportunity to work at the intersection of AI/ML and drug discovery during a critical growth phase in computational biology
- Heavy IT/automation hiring (5 IT roles, 1 lab automation role) signals investment in platform infrastructure and technical infrastructure
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for insitro
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.